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Abstract: Background. The purpose of this study was to
test whether nutritional status of patients with head and neck
cancer changes during and after treatment.
Methods. Nutritional status (including body weight, lean
mass, and fat mass) and dietary intake were assessed in 29
patients with head and neck cancer. Patients were assessed
1 week before, and 1 and 4 months after treatment (radiotherapy,
either alone or combined with chemotherapy or surgery).
Results. During treatment, body weight (3.6  5.3 kg;
p ¼ .019) and lean mass (2.43  2.81 kg; p ¼ .001) signiﬁ-
cantly declined. Patients with sufﬁcient intake (35 kcal and
1.5 grams protein/kg body weight) lost less body weight and
lean mass than patients with insufﬁcient intake (mean differ-
ence, 4.0  1.9 kg; p ¼ 0.048 and 2.1  1.0 kg; p ¼ .054,
respectively). After treatment, only patients with sufﬁcient
intake gained body weight (2.3  2.3 kg) and lean mass
(1.2  1.3 kg).
Conclusion. Patients with head and neck cancer fail to
maintain or improve nutritional status during treatment, despite
sufﬁcient intake. VC 2010 Wiley Periodicals, Inc. Head Neck
33: 863–870, 2011
Keywords: malnutrition; nutritional status; lean mass; head and
neck cancer; radiotherapy
Malnutrition has been deﬁned as a subacute or
chronic state of nutrition in which a combination of
undernutrition (insufﬁcient food intake) and inﬂamma-
tion has led to a decrease in muscle mass and fat
mass, and diminished immune function, cognitive func-
tion, and muscle strength.1 Malnutrition is a common
problem in patients with head and neck cancer. Pre-
treatment prevalence of severe weight loss, an indica-
tor of malnutrition, ranges from 19% to 57%.2–4
Malnutrition may have multiple causes in patients
with head and neck cancer. In the period before treat-
ment, a major cause of malnutrition is insufﬁcient food
intake, related to mechanical obstruction of food or
pain related to the tumor. In addition, cancer cachexia
may contribute to malnutrition.1 Cachexia is a complex
metabolic syndrome associated with underlying illness
and characterized by loss of muscle with or without
loss of fat mass.5 During and after treatment, malnu-
trition may develop or aggravate as a result of reduced
dietary intake due to treatment-related oral symptoms,
such as chewing and swallowing problems, pain, dry
mouth, sticky saliva, and taste disturbances.6 Further-
more, cancer treatment may induce inﬂammation,
either directly due to surgery7 or indirectly due to (che-
mo)radiation-induced mucositis.8 This inﬂammation
may in turn result in (further) loss of muscle mass.9,10
Little is known about changes in body composition
in patients with head and neck cancer. Assessment of
changes in body composition is of clinical importance.
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In malnourished patients, lean mass depletion (ie, mus-
cle mass depletion is responsible for the impaired
immune function), which in turn results in a higher
risk for postoperative complications and reduced
response to cancer treatment.11 Moreover, lean mass
depletion is associated with reduced physical activity,
reduced quality of life, and prolonged length of hospital
stay.1,12
In previous prospective studies on malnutrition in
patients with head and neck cancer, various methods
to assess nutritional status have been used. In some
studies, nutritional status was assessed by means of
changes in body weight13 or Patient Generated Sub-
jective Global Assessment (PG-SGA).14,15 The PG-
SGA is a nutritional assessment tool that assesses
changes in body weight, presence of symptoms, and
evaluates changes in dietary intake and body composi-
tion. These studies demonstrated improvement in
nutritional status in patients receiving dietary counsel-
ing during radiotherapy14,15 and deterioration of nutri-
tional status in patients not receiving dietary
intervention.13–15 It is unknown, however, if and to
what extent lean mass changed in these studies. Two
other studies assessed body composition prospectively
in patients with head and neck cancer.16,17 In both
studies, body weight and lean mass declined signiﬁ-
cantly during head and neck cancer treatment despite
dietary counseling.17 Another study assessed lean
mass and PG-SGA prospectively in a mixed group of
patients with head and neck cancer or gastrointestinal
cancer receiving radiotherapy.14 In that study, patients
randomized to dietary counseling had signiﬁcantly
smaller deterioration of PG-SGA than patients not
receiving dietary counseling, but they had no signiﬁ-
cant improvement in body weight and lean mass during
treatment.14 The validity of assessment of lean mass in
that study was limited, due to use of foot-to-foot bio-
electrical impedance analysis. This method leads to
unacceptable errors in predicting lean mass.18 Cur-
rently, it remains unclear whether improvement of
nutritional status or body weight in patients with head
and neck cancer is characterized by improvement of
lean mass. The pitfall is that gain of body weight is
characterized by mainly fat mass, whereas improve-
ment in lean mass is the goal.
The primary purpose of this prospective cohort
study was to test whether nutritional status, including
lean mass, changes during and after head and neck
cancer treatment including radiotherapy or chemoradia-
tion. The secondary purpose was to assess energy and
protein intake, grip strength, phase angle, and perform-
ance status during and after treatment, since these
variables are related to nutritional status.19–22
PATIENTS AND METHODS
A consecutive series of 59 adult patients was asked to
participate in this prospective study between March
2008 and September 2009. All patients were treated for
head and neck cancer within the setting of the multi-
disciplinary head and neck cancer group of the Univer-
sity Medical Centre Groningen and Medical Centre
Leeuwarden, The Netherlands. Patients willing to par-
ticipate were assessed after a scheduled visit at the
hospital. Diagnosis and treatment information were
retrieved from medical records and included tumor
localization, tumor size, type of head and neck cancer
treatment, and date of start and ending of head and
neck cancer treatment. The study was approved by and
performed according to the standards of the Ethics
Committee of the University Medical Centre Gro-
ningen and Medical Centre Leeuwarden. Informed con-
sent was obtained from all participants.
Inclusion criteria were: age 18 years; primary or
recurrent squamous cell carcinoma in the oral cavity, oro-
pharynx, hypopharynx or larynx; treatment with curative
radiotherapy (including unilateral or bilateral neck irradi-
ation) either alone or in combination with chemotherapy
or after surgery.
Exclusion criteria were: secondary tumor in
another region than the head or neck; a recurrent, re-
sidual, or new tumor diagnosed within the study pe-
riod. Comorbidity also may have a signiﬁcant impact
on nutritional status and thus might serve as a possible
confounding risk factor for weight loss or lean mass
depletion. Therefore, patients with edema due to liver,
kidney disease, cardiac disease, muscular disease, and
uncontrolled diabetes mellitus were also excluded.
All patients received individual dietary counseling
during the study period, on admission for surgery
and weekly during radiotherapy. Dietary counseling
included advice on modiﬁcation of food texture to alle-
viate treatment-related oral symptoms like mucositis
and dry mouth. To meet nutritional objectives of 35
kcal/kg body weight and 1.5 gram protein/kg body
weight,11,23 tube feeding or liquid dietary supple-
ments were prescribed, either postsurgery or during
radiotherapy or in posttreatment period.
Study Measurements. Study assessments were car-
ried out 3 times. The ﬁrst study measurement (T0) was
performed in the week before the start of treatment. In
this study measurement, body height, body weight,
lean mass, fat mass, phase angle, grip strength, per-
formance status, and dietary intake were assessed. Sec-
ond (T1) and third (T2) study measurements were
performed 1 month and 4 months after the end of treat-
ment, respectively. At these time points, assessment of
all variables was repeated, except for body height.
Patients were not allowed to eat or drink during 4
hours preceding the measurements. Patients were
measured in their underwear and without shoes, af-
ter voiding the bladder. Body height was measured by
a stadiometer (Seca 222, Medical Scales & Measuring
Systems Seca, United Kingdom). Body weight was
measured on a calibrated Seca 701 scale (Medical
Scales & Measuring Systems) to the nearest 0.1 kg.
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Patients were asked for their body weight (without
clothes and shoes) 6 months and 1 month before the
start of treatment. The percentage of weight loss in the
last month was calculated as
ðbody weight 1 month ago actual body weight=
body weight 1 month agoÞ  100:
Percentage of weight loss in the last 6 months
was calculated as
ðbody weight 6 months agoactual body weight=
body weight 6 months agoÞ  100:
Malnutrition was deﬁned as weight loss 10% in
the last 6 months or 5% in the last month.4,24–26
Body mass index (BMI kg/m2) was calculated as
actual body weight/height2. BMI was classiﬁed as:
underweight (BMI <18.5 kg/m2), normal (BMI 18.5–25
kg/m2), overweight (BMI >25–30 kg/m2) or obese (BMI
>30 kg/m2).27
Dual energy x-ray scans were performed to mea-
sure lean mass, fat mass, and bone mineral content,
with a Hologic Discovery A (Hologic, Bedford, MA).
Changes in total lean mass, total fat mass, and
changes in regional lean mass and fat mass (arms,
legs, and trunk) were analyzed. Lean mass index (kg/
m2) was calculated as lean mass/height2.12 Fat mass
index (kg/m2) was calculated as fat mass/height2.12
Change in body weight and lean mass of 0.5 kg
were considered clinically relevant. Lean mass and
fat mass depletion were deﬁned as lean mass index
and fat mass index <10th percentile.28 Lean mass
index eliminates differences in lean mass associated
with height.
Grip strength was measured as operationalization
of muscle strength, by means of a hydraulic hand
dynamometer (Jamar) in a sitting position, on the
nondominant hand, and with the elbow ﬁxed at
90 degrees. The mean of 3 readings was used in the
analysis.29
Bioelectrical impedance analysis was used to mea-
sure resistance and reactance, using Bodystat QuadS-
can 4000 (Bodystat). Patients were in a supine position
15 minutes before measurement. Phase angle was cal-
culated as arc-tangent (reactance/resistance)  180/p
and expressed in degrees. A smaller phase angle, as
observed in malnourished patients, suggests decreased
cell integrity or cell death, whereas a larger phase
angle suggests large quantities of intact cell
membranes.21 Besides the function as nutritional indi-
cator,21,30,31 phase angle is a prognostic indicator as
well.21,30,32 Phase angle is independent of regression
equations and can be performed even in situations in
which bioelectrical impedance analysis assumptions
are not valid.30
Performance status was graded by World Health
Organization score.33 Grades vary from 0 (‘‘Fully
active, able to carry on all pre-disease performance
without restriction.’’) to 4 (‘‘Completely disabled. Can-
not carry on any selfcare. Totally conﬁned to bed or
chair.’’).
Dietary intake of the last week before study mea-
surement was assessed by a registered dietician (H.J.),
by means of dietary history.34 Energy and protein
intake were calculated using food calculation software
(JOULE version 02r80 by iSOFT, The Netherlands).
Intake of 35 kcal/kg and 1.5 grams protein/kg body
weight was considered sufﬁcient.11,23
Statistical Analysis. Statistical analyses were per-
formed using SPSS 16.0 for Windows software (SPSS,
Chicago, IL). Descriptive statistics were used to sum-
marize baseline patient characteristics. Results are
expressed as mean  SD, unless stated otherwise.
Changes in body weight, lean mass, lean mass index,
fat mass, fat mass index, grip strength, and phase
angle over time were analyzed by General Linear
Model repeated measures, using type of treatment (sur-
gery and radiotherapy/chemoradiation vs radiother-
apy/chemoradiation) as within-subject factor. In case of
deviation from sphericity, a Greenhouse Geisser correc-
tion for degrees of freedom was used. Changes in per-
formance status over time were analyzed by the
Wilcoxon rank sum test. Differences in continuous vari-
ables between the 2 groups were analyzed by independ-
ent sample t tests and 1-way analysis of variance
between 3 groups. Pearson correlation coefﬁcient r was
used to analyze the relationship between 2 continuous
variables. In all analyses, statistical signiﬁcance was
set at p< .05.
RESULTS
Thirty-ﬁve patients could be included in the study (59%
participation rate). Themain reason for not being willing
to participate in the study was expected physical or men-
tal burden of participation (n ¼ 16). Other reasons for no
participation were: too busy due to the disease itself (n ¼
6) and not interested (n ¼ 2). No signiﬁcant differences
in body weight and BMI were found between partici-
pants and nonparticipants. However, signiﬁcantly more
nonparticipants were treated with radiotherapy/chemo-
radiation (71%; n ¼ 17) than participants (31%; n ¼ 9; p
¼ .004).
During the study period, 1 patient was excluded
because no indication for postoperative radiotherapy
existed anymore. During the study period, 5 patients
dropped out. Between T0 and T1, 1 malnourished patient
died and 3 patients, of which 2 were malnourished,
dropped out due to fatigue. Between T1 and T2, a well-
nourished patient died. Twenty-nine patients completed
all measurements.
Phase angle measurements were performed in 27
patients, because in 2 patients bioelectrical imped-
ance analysis could not be performed due to the pres-
ence of metal prostheses. In all other measurements,
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data of 29 patients were used in the analysis. Base-
line patient characteristics are shown in Table 1.
Body weight of patients treated with surgery and
radiotherapy/chemoradiation was signiﬁcantly higher
(79.5  18.0 kg) than of patients treated with primary
radiotherapy/chemoradiation (69.0  20.2 kg).
Pretreatment prevalence of malnutrition was 17% (5
of 29). Malnourished patients had cancer in the supra-
glottic larynx (n ¼ 2), tongue (n ¼ 1), and hypopharynx
(n ¼ 2). Four malnourished patients had received dietary
intervention before T0.
Five patients (25%) treated with surgery and
radiotherapy/chemoradiation and 6 patients treated
with radiotherapy/chemoradiation (67%) had received
dietary counseling before the start of treatment. In
total, 13 patients (45%) were (partially) fed by tube
feeding during radiotherapy. Twelve patients (41%)
had received a prophylactic gastrostomy prior to the
start of their treatment, of which 3 patients were
treated with surgery and radiotherapy, 5 patients
with primary chemoradiation, and 4 patients with
surgery and chemoradiation. Two patients (7%) who
were treated with surgery and chemoradiation did
not use their gastrostomy. One of these 2 patients did
not want to use tube feeding and in the other patient
the gastrostomy had to be removed early due to infec-
tion. One patient (3%) used tube feeding by a naso-
gastric tube during treatment with chemoradiation,
because prophylactic placement of a gastrostomy was
not possible. One patient (3%) received therapeutic tube
feeding by a nasogastric tube during radiotherapy.
Changes in Nutritional Status and Performance
Status. As shown in Table 2, body weight, BMI, and
lean mass signiﬁcantly declined during treatment
(p < .05). In this period, patients lost 3.6  5.3 kg of
body weight, which was 4.7% of pretreatment body
weight. Sixty-two percent of weight loss was loss of
lean mass (2.4  2.8 kg), which was 4.5% of pretreat-
ment lean mass. Lean mass declined signiﬁcantly in
all body regions (arms, legs p < .001; and trunk p <
.05). Prevalence of malnutrition shortly after treat-
ment (at T1) increased to 52% (15 of 29).
Overall, no signiﬁcant changes in body weight,
BMI, and lean mass were found between ﬁrst and
second posttreatment assessment (between T1 and T2,
Table 2). Ten patients (34%) lost body weight and lean
mass both during and after treatment. At second post-
treatment assessment, 11 patients (38%) had returned
their body weight to their pretreatment level. Preva-
lence of malnutrition at second posttreatment assess-
ment declined to 24% (7 of 29).
In men, lean mass tended to be depleted pretreat-
ment and was depleted posttreatment (lean mass
index <17.6 for men aged 35–74 years, Table 2).28 In
women, lean mass depletion (lean mass index <14.6–
14.7 for women aged 35–74 years)28 was observed
both pretreatment and posttreatment. Neither in men
nor women fat mass depletion was observed. A higher
fat mass at T0 was signiﬁcantly related to loss of lean
mass during treatment (r ¼ 0.51; p ¼ .005).
Loss of body weight and lean mass during and af-
ter treatment did not differ per age (65 years vs
<65 years), sex, tumor size (T1/T2 vs T3/T4), type of
treatment (primary radiotherapy or chemoradiation
vs surgery and radiotherapy, or surgery and chemora-
diation), baseline nutritional status (malnutrition yes/
no), and use of tube feeding (yes/no). However, a sig-
niﬁcant interaction between time and type of treat-
ment was observed for changes in lean mass index
over time (p < .048).
Grip strength signiﬁcantly declined during treat-
ment and signiﬁcantly increased after treatment (p <





















Surgery þ radiotherapy 16 55
Chemoradiation 6 21










<18.5 (underweight) 5 17
18.5–25 (normal weight) 13 45
>25–30 (overweight) 6 21
>30 (obese) 5 17
BMI, mean (SD), kg/m2
Male 24.7 (5.2)
Female 21.8 (5.8)
Lean mass index, mean (SD), kg
Male 17.9 (2.5)
Female 14.2 (2.4)
Fat mass index, mean (SD), kg
Male 6.2 (3.0)
Female 7.2 (3.4)
Abbreviations: WHO, World Health Organization; BMI, body mass index.
*Sum of percentages may be dissimilar to 100%, due to rounding.
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.001; Table 2). Decline in grip strength during treat-
ment was signiﬁcantly related to decline in body weight
(r ¼ 0.42; p ¼ .023) and decline in lean mass (r ¼ 0.49; p
¼ .007) in this period. Such a relationship was not
found after treatment (between T1 and T2).
Phase angle did not signiﬁcantly change over time
(Table 2). However, decrease in phase angle during
treatment was signiﬁcantly related to decrease in
lean mass in this period (r ¼ 0.51; p ¼ .007).
Median performance status signiﬁcantly de-
creased during treatment from 0 (‘‘Fully active. Able
to carry out all normal activity without restriction’’)
to 1 (‘‘Restricted in physically strenuous activity but
ambulatory and able to carry out light work’’; p ¼
.013), and signiﬁcantly recovered to 0 in the period af-
ter treatment (p ¼ .003).
Dietary Intake. As shown in Table 3, energy and
protein intake did not change over time. However, a
signiﬁcant interaction between time and type of treat-
ment was observed for changes in energy intake over
time (p ¼ .033; Figure 1).
Patients with a sufﬁcient intake during treatment
lost signiﬁcantly less body weight (mean difference 4.0
 1.9 kg; p ¼ .048) and lean mass (mean difference 2.1
 1.0 kg; p ¼ .054) than patients with an insufﬁcient
intake (Table 4). Furthermore, patients with a sufﬁ-
cient intake in the period after treatment gained body
weight and lean mass, whereas patients with an insuf-
ﬁcient intake lost body weight (mean difference 3.7 
0.9 kg; p < .001) and lean mass (2.0  0.6 kg; p ¼ .001)
in this period.
No signiﬁcant differences in dietary intake were
found between patients with and without tube feeding
during radiotherapy/chemoradiation. Five of 13 patients
(39%) using tube feeding had sufﬁcient intake during
radiotherapy/chemoradiation.
Frequency of insufﬁcient intake was signiﬁcantly
higher in overweight/obese patients (91%) than in
normal weight (54%) or underweight patients (20%; p
¼ .021).
DISCUSSION
Our study is 1 of the few studies that longitudinally
performed advanced nutritional assessments in
patients with head and neck cancer and related nutri-
tional status to dietary intake. Patients in the current
study were not able to maintain or improve lean mass
during head and neck cancer treatment. Instead,
patients lost about 5% of their pretreatment body
weight, of which nearly two-thirds was loss of lean
mass.
Generally, loss of body weight and lean mass are
known to be the result of negative energy and protein
balance.9,11 The observed loss of body weight and lean
mass during cancer treatment may point toward
insufﬁcient dietary intake. Whereas dietary intake of
our patients was in line with the current recommen-
dations of 30 to 35 kcal/kg and 1.2 to 2.0 gram
Table 3. Changes in dietary intake during and after head and neck cancer treatment.
T0 T1 T2 p value*
Total energy, mean (SD), kcal 2448.7 (769.3) 2540.6 (745.5) 2652.8 (795.1) .849
Energy/body weight, mean (SD), kcal/kg 34.2 (13.9) 36.2 (11.6) 37.9 (14.2) .853
Energy/lean mass, mean (SD), kcal/kg 46.9 (17.6) 49.4 (14.5) 52.3 (17.7) .749
Total protein, mean (SD), g 90.1 (29.0) 98.9 (30.2) 102.3 (31.5) .596
Protein/body weight, mean (SD), g/kg 1.3 (0.5) 1.4 (0.5) 1.5 (0.5) .416
Protein/kg lean mass, mean (SD), g/kg 1.7 (0.6) 1.9 (0.6) 2.0 (0.7) .372
*Analyzed by General Linear Model repeated measures, using type of treatment (surgery plus radiotherapy/chemoradiation vs radiotherapy/ chemoradiation) as within-subject
factor.
Table 2. Changes in nutritional status during and after head and neck cancer treatment.
T0 T1 T2 p value
Body weight, mean (SD), kg 76.3 (19.0) 72.7 (16.5) 73.0 (15.0) .019*,†
Body mass index, mean (SD), kg/m2 24.1 (5.4) 23.0 (4.6) 23.1 (4.0) .024*,†
Lean mass, mean (SD), kg 54.6 (11.4) 52.1 (10.7) 52.3 (10.3) .001†,‡
Lean mass index, mean (SD), kg/m2 17.2 (2.9) 16.5 (2.5) 16.6 (2.3) .065†,§
Fat mass, mean (SD), kg 20.0 (9.8) 18.9 (8.1) 19.0 (7.0) .298†
Fat mass index, mean (SD), kg/m2 6.4 (3.1) 6.1 (2.5) 6.1 (2.2) .502†
Grip strength, mean (SD), kg 39.8 (12.8) 35.3 (12.2) 37.0 (12.2) <.001†,||
Phase angle, mean (SD),  6.3 (0.8) 5.8 (0.1) 6.0 (1.4) .077¶
*p < .05 (T0–T1).
†Analyzed by General Linear Model repeated measures, using type of treatment (surgery plus radiotherapy/chemoradiation vs radiotherapy/ chemoradiation) as within-subject
factor. A Greenhouse Geisser correction for degrees of freedom was used because of deviation from sphericity.
‡p < .05 (T0–T1; T0–T2).
§Interaction between time and type of treatment (patients treated with surgery plus radiotherapy/chemoradiation versus patients treated with radiotherapy/chemoradiation) (p <
.05).
||p < .05 (T0–T1; T1–T2; T0–T2).
¶Analyzed by Wilcoxon rank sum test.
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protein/kg body weight,11 and whereas protein intake
of 1.5 to 1.7 gram/kg body weight has generally been
proposed as ‘‘optimal’’ to preserve lean mass in ambu-
lant patients,23 the optimal amount of energy and
protein to preserve lean mass in patients with head
and neck cancer is still unknown. In the current
study, patients with an intake of 35 kcal/kg and
1.5 gram protein/kg still had their lean mass
declined (1.2  3.3 kg). Post-hoc analysis revealed
that if the cutoff score for sufﬁcient protein intake
was raised to 1.7 gram/kg body weight, the accompa-
nied decline in body weight and lean mass were not
signiﬁcantly or clinically relevantly smaller than
when using the cutoff score of 1.5 gram protein/body
weight. Because the number of patients with an
intake of >1.7 gram protein/kg body weight was
rather small (n ¼ 8), this ﬁnding should be validated,
that the current recommendations for dietary intake
proposed in the literature need reappraisal.
Dietary intake of the patients in the current study
was higher than that of patients in other head and neck
cancer studies.14–17 Only 1 of these studies reported
improvement in nutritional status during treatment
with radiotherapy after induction chemotherapy.15
Unfortunately, in that study, body composition was not
assessed. As a result, it cannot be ruled out that
increase in fat mass, rather than lean mass, was re-
sponsible for the gain in body weight observed in that
study.
Inﬂammatory activity related to disease or treat-









































































































































































































































































































































































































































































































































































































































































































































































































FIGURE 1. Changes in dietary intake as expressed by energy
end protein intake during and after treatment, per type of treat-
ment. n, Energy, surgery þ RT/CRT*; h, Energy, RT/CRT; ~,
Protein, surgery þ RT/CRT; ~, Protein, RT/CRT; RT, radio-
therapy; CRT, chemoradiation. *A signiﬁcant interaction
between time and type of treatment was found in changes in
energy intake over time (p ¼ .033), analyzed by General Linear
Model repeated measures, using type of treatment (surgery
plus radiotherapy/chemoradiation vs radiotherapy/chemoradia-
tion) as within-subject factor.
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breakdown. Additionally, physical inactivity may
hamper protein synthesis.9,11 Because intake of 35
kcal/kg and 1.5 gram protein/kg body weight could
not preserve lean mass during treatment but could so
in the posttreatment period, it may be assumed that
patients with head and neck cancer subjected
to intensive cancer treatment are physically inactive
due to fatigue, or suffer from inﬂammatory activity.
During treatment, patients were restricted in physi-
cally strenuous activity but remained ambulant and
were still able to carry out light work. This moderate
deterioration of performance status may have contrib-
uted to loss of lean mass during treatment.
Literature on inﬂammatory activity in patients with
head and neck cancer points toward the presence of
inﬂammatory activity during radiotherapy. Increased C-
reactive protein levels have been reported in patients
with head and cancer during and shortly after radiother-
apy.8,35,36 Furthermore, elevated levels of interleukin-1ß,
interleukin-6, interleukin-8, and C-reactive protein were
found in patients with head and neck cancer before and
shortly after treatment with induction chemotherapy fol-
lowed by chemoradiation.17 In the latter study, posttreat-
ment levels of inﬂammatory markers were not
signiﬁcantly higher than pretreatment levels. Increased
inﬂammatory activity during radiotherapy has been
associated with radiation-induced mucositis.35,37 More
knowledge concerning the level and duration of inﬂam-
matory activity per treatment modality is needed. Fur-
thermore, more insight in the effect of inﬂammatory
activity on energy expenditure and protein breakdown in
patients with head and neck cancer is needed.
In the current study, lean mass depletion (lean
mass index<10th percentile) was observed despite nor-
mal BMI values, similar to previous ﬁndings.38 Addi-
tionally, our study demonstrated that despite a
substantial decrease in prevalence of malnutrition in
the ﬁrst 4 months posttreatment, patients fail to regain
lean mass during this period. Obviously, body composi-
tion measurements provide valuable information about
nutritional status in addition to more general and less
speciﬁc methods as body weight and BMI.
In the current study, even in the absence of a spe-
ciﬁc physical exercise training, gain of lean mass was
observed in patients having a sufﬁcient intake (35
kcal/kg and 1.5 gram protein/kg body weight)
between the ﬁrst and fourth month after treatment.
Protein anabolism may be stimulated by physical
exercise, as physical exercise ameliorates the efﬁ-
ciency in using dietary protein.9 In survivors of hema-
tological malignancies and breast cancer who
experienced severe weight loss during high-dose
chemotherapy followed by stem cell transplantation, a
12-week physical exercise program resulted in an
increase of lean mass of more than 6 kg, in contrast to
the control group.39 Although sample size in that study
was small, the effect observed of physical exercise on
gain of lean mass is encouraging and may be beneﬁcial
for patients with head and neck cancer.
Surprisingly, more than one-third of the patients
using tube feeding did not meet the nutritional goals
of 35 kcal/kg and 1.5 grams protein/kg body
weight. The majority of the patients using tube feed-
ing were treated with chemoradiation (77%). Insufﬁ-
cient intake in these patients may be related to
nausea. Nausea is frequently present in patients
treated with chemoradiation and is less frequently
present in patients treated with radiotherapy alone.40
More insight is needed in factors contributing to
insufﬁcient intake in patients using tube feeding.
Grip strength and performance status decreased
during treatment and increased after treatment. These
changes in grip strength were positively related to
changes in lean mass during treatment, but not after
treatment. Improvement of muscle strength in absence
of improvement in lean mass is also seen in obese sub-
jects41 and in patients with anorexia nervosa,42 during
refeeding after a period of hypocaloric feeding. It has
been suggested that nutrition exerts effects on muscle
strength independently of muscle mass.26 Additionally,
a negative association between grip strength and
inﬂammatory activity has been reported.20,43 There-
fore, the observed increase in grip strength in the post-
treatment period may reﬂect decreased inﬂammatory
activity.
Although a relationship between phase angle and
nutritional status has been demonstrated in other
studies,21,31,44 our study is the ﬁrst that found a rela-
tionship between changes in phase angle and changes
in lean mass during head and neck cancer treatment.
The current study has some limitations. First, the
participation rate (59%) was lower than expected,
mainly due to expected physical or mental burden of
repeated study measurements (67%). Furthermore,
60% of the patients that dropped out due to fatigue or
death were malnourished. As a result, prevalence of
malnutrition is underestimated. Second, energy expendi-
ture was not measured in our study. Unfortunately, it was
not feasible to perform indirect calorimetry measure-
ments in the current study protocol, as we needed to mini-
mize burden (eg, duration of fasting) to patients who are
already in an aggravating phase of their lives. As a result,
we had to estimate energy requirements. Use of prediction
equations to predict energy expenditure may lead to pre-
diction errors.45,46 Such prediction errors may vary from
235 to 425 kcal, which is about 15% to 30% of resting
energy expenditure as measured by indirect
calorimetry.46
In conclusion, loss of body weight and lean mass
during intensive head and neck cancer treatment
occurred despite internationally recommended energy
and protein intake. The results of this study illustrate
that more insight in total and resting energy expendi-
ture, insight in the effect of inﬂammatory activity,
and reduced physical activity on loss of lean mass in
patients with head and neck cancer during and after
treatment is needed.
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